PubMed (OMIM) for id: 940

Year	Number of Results
1987	1
1988	1
1990	2
1991	1
1992	1
1999	1
2001	1
2003	1
2004	1
2011	1
2015	1
2017	2
2024	0

1

Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.

Kamphorst AO, Wieland A, Nasti T, Yang S, Zhang R, Barber DL, Konieczny BT, Daugherty CZ, Koenig L, Yu K, Sica GL, Sharpe AH, Freeman GJ, Blazar BR, Turka LA, Owonikoko TK, Pillai RN, Ramalingam SS, Araki K, Ahmed R. Kamphorst AO, et al. Science. 2017 Mar 31;355(6332):1423-1427. doi: 10.1126/science.aaf0683. Epub 2017 Mar 9. Science. 2017. PMID: 28280249 Free PMC article.

2

T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.

Hui E, Cheung J, Zhu J, Su X, Taylor MJ, Wallweber HA, Sasmal DK, Huang J, Kim JM, Mellman I, Vale RD. Hui E, et al. Science. 2017 Mar 31;355(6332):1428-1433. doi: 10.1126/science.aaf1292. Epub 2017 Mar 9. Science. 2017. PMID: 28280247 Free PMC article.

3

Defects in regulatory T cells due to CD28 deficiency induce a qualitative change of allogeneic immune response in chronic graft-versus-host disease.

Akieda Y, Wakamatsu E, Nakamura T, Ishida Y, Ogawa S, Abe R. Akieda Y, et al. J Immunol. 2015 May 1;194(9):4162-74. doi: 10.4049/jimmunol.1402591. Epub 2015 Mar 30. J Immunol. 2015. PMID: 25825447

4

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.

Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, Baker J, Jeffery LE, Kaur S, Briggs Z, Hou TZ, Futter CE, Anderson G, Walker LS, Sansom DM. Qureshi OS, et al. Science. 2011 Apr 29;332(6029):600-3. doi: 10.1126/science.1202947. Epub 2011 Apr 7. Science. 2011. PMID: 21474713 Free PMC article.

5

Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation.

Andres PG, Howland KC, Nirula A, Kane LP, Barron L, Dresnek D, Sadra A, Imboden J, Weiss A, Abbas AK. Andres PG, et al. Nat Immunol. 2004 Apr;5(4):435-42. doi: 10.1038/ni1044. Epub 2004 Mar 7. Nat Immunol. 2004. PMID: 15004555

6

A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).

Harada Y, Ohgai D, Watanabe R, Okano K, Koiwai O, Tanabe K, Toma H, Altman A, Abe R. Harada Y, et al. J Exp Med. 2003 Jan 20;197(2):257-62. doi: 10.1084/jem.20021305. J Exp Med. 2003. PMID: 12538664 Free PMC article.

7

A point mutation in CD28 distinguishes proliferative signals from survival signals.

Okkenhaug K, Wu L, Garza KM, La Rose J, Khoo W, Odermatt B, Mak TW, Ohashi PS, Rottapel R. Okkenhaug K, et al. Nat Immunol. 2001 Apr;2(4):325-32. doi: 10.1038/86327. Nat Immunol. 2001. PMID: 11276203

8

Identification of three alternatively spliced variants of human CD28 mRNA.

Magistrelli G, Jeannin P, Elson G, Gauchat JF, Nguyen TN, Bonnefoy JY, Delneste Y. Magistrelli G, et al. Biochem Biophys Res Commun. 1999 May 27;259(1):34-7. doi: 10.1006/bbrc.1999.0725. Biochem Biophys Res Commun. 1999. PMID: 10334911

9

Purification and N-terminal amino acid sequence of the human T90/44 (CD28) antigen.

Lesslauer W, Gmünder H, Böhlen P. Lesslauer W, et al. Immunogenetics. 1988;27(5):388-91. doi: 10.1007/BF00395136. Immunogenetics. 1988. PMID: 2833438 No abstract available.

10

Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.

Aruffo A, Seed B. Aruffo A, et al. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8573-7. doi: 10.1073/pnas.84.23.8573. Proc Natl Acad Sci U S A. 1987. PMID: 2825196 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year